My watch list  

Adiposogenital dystrophy

Adiposogenital dystrophy
Classification & external resources
ICD-10 E23.6
ICD-9 253.8
DiseasesDB 29318

Adiposogenital dystrophy is a medical condition.



It is characterized by:

It is usually associated with tumours of the hypothalamus, causing increased appetite and depressed secretion of gonadotropin. It seems to affect males mostly.

Many overweight children may appear to have the disorder because of the concurrence of obesity and retarded sexual development; these children have no endocrine disturbances, however, and they mature normally after delayed puberty.


It has several other names:[1]

See also


  1. ^ National Organisation for Rare Disorders - Froelich's syndrome
  2. ^ synd/1792 at Who Named It - Babinski-Fröchlich syndrome
  3. ^ J. F. Babinski. Tumeur du corps pituitaire sans acromégalie et avec arrêt de développement des organes génitaux. Revue neurologique, Paris, 1900, 8: 531-535.
  4. ^ A. Fröhlich. Ein Fall von Tumor der Hypophysis cerebri ohne Akromegalie. Wiener klinische Rundschau, 1901, 15: 833-836; 906-908.
  5. ^ Zárate A, Saucedo R (2007). "[The adiposogenital distrophy or Frohlich syndrome and the beginning of the concept of neuroendocrinology]" (in Spanish; Castilian). Gac Med Mex 143 (4): 349–50. PMID 17969845.
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Adiposogenital_dystrophy". A list of authors is available in Wikipedia.
Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE